Bronstein, Gewirtz & Grossman, LLC Announces Investigation of LifeVantage Corporation
NEW YORK, Dec. 6, 2012 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of LifeVantage Corporation. ("LifeVantage" or the "Company") (NasdaqCM:LFVN-News), concerning potential violations of federal securities laws.
On December 6, 2012, shares of LifeVantage fell 54 cents or 21%, trading at $1.96 during intraday trading after announcing a voluntary recall for and replace bottles of its Protandim®, the Nrf2 Synergizer®, a dietary supplement. The Company is taking this action due to the possible inclusion of small metal fragments in the final product. The fragments were originally discovered in batches of turmeric extract, an ingredient in Protandim® that was purchased from a third party supplier. The Company estimates that the gross cost could be as high as $7 million before recovery from suppliers and expects the costs to be primarily reflected in the Company's second fiscal quarter results.
If you are aware of any facts relating to this investigation, or purchased shares of LifeVantage, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
More by this Source
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
May 22, 2013, 16:05 ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iGATE Corporation
May 22, 2013, 08:30 ET
Bronstein, Gewirtz & Grossman, LLC Notifies Investors with Losses on Their Investment in Accretive Health, Inc. of Class Action Lawsuit and the Deadline to Seek a Lead Plaintiff Position
May 21, 2013, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.